Leucovorin calcium administration and preparation
Lauper, R.D.
American Journal of Hospital Pharmacy 35(4): 377-378
1978
ISSN/ISBN: 0002-9289 PMID: 306195 Document Number: 125713
Document emailed within 1 workday
Related Documents
Rodman, J.H.; Crom, W.R. 1989: Selecting an administration route for leucovorin rescue Clinical Pharmacy 8(9): 617; 621Madajewicz, S.; Petrelli, N.; Rustum, Y.M.; Campbell, J.; Herrera, L.; Mittelman, A.; Perry, A.; Creaven, P.J. 1984: Phase I-Ii trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer Cancer Research 44(10): 4667-4669
Yuasa, C.; Okabe, H.; Toko, T.; Takeda, S.; Unemi, N. 1995: Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(13): 1927-1932
Grem, J.L.; McAtee, N.; Steinberg, S.M.; Hamilton, J.M.; Murphy, R.F.; Drake, J.; Chisena, T.; Balis, F.; Cysyk, R.; Arbuck, S.G. 1993: A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma Cancer Research 53(20): 4828-4836
Kuwa, K.; Sakamoto, S.; Sassa, S.; Yoshimura, S.; Maemura, M.; Nakayama, T. 1999: Effects of long-term administration of UFT plus leucovorin on colorectal tumors induced with 1,2-dimethylhydrazine in rats Anticancer Research 19(6b): 5139-5142
Okabo, S.; Arai, T.; Maruyama, S.; Lee, M.; Murase, N.; Tsubaki, M.; Endo, M.; Wada, Y.; Shimoju, K.; Sakurazawa, K.; Sugihara, K.; Maruyama, M.; Yabata, E.; Kawasaki, T.; Sasaki, T. 1997: A randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP 5-FU and dl-leucovorin for colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(7): 849-854
Kovalcík, V.; Hrková, V. 1975: Effect of calcium chloride on calcium content in aortal tissue after administration of reserpin and guanetidin Bratislavske Lekarske Listy 64(5): 590-596
Drábková, E.; Lazarová, Z.; Edelsteinová, S.; Czirfusz, A.; Gratzlová, J.; Holub, P. 1992: The effect of calcium antagonists on total calcium and magnesium levels in the aorta of rabbits after administration of dietary cholesterol Casopis Lekaru Ceskych 131(5): 146-148
Brazier, M.; Sebert, J.L. 1997: Comparison of calcium retention measured using a radionuclide method after administration of 1000 mg elemental calcium in two different galenic forms, in one or two doses Revue du Rhumatisme 64(12): 857-858
Sasaki, T.; Ota, K.; Taguchi, T.; Ogawa, N.; Kurihara, M.; Akazawa, S.; Ogawa, M.; Tominaga, T.; Konishi, T.; Kumai, K. 1995: A randomized early phase Ii study of l-leucovorin and 5-fluorouracil in gastric cancer. l-Leucovorin and 5-FU Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 521-529
Smith, R.E.; Lembersky, B.C.; Wieand, H.S.; Colangelo, L.; Mamounas, E.P. 2000: UFT/leucovorin vs 5-FU/leucovorin in colon cancer Oncology 14(10 Suppl 9: 24-27
Kalofonos, H.P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K.N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G. 2010: Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer Anticancer Research 30(10): 4325-4333
Ohtani, H.; Arimoto, Y.; Nishio, K.; Kanamiya, Y.; Oba, H.; Adachi, K.; Shintani, M.; Nakamura, R.; Yui, S. 2008: Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1769-1774
Relyveld, E.H. 1986: Preparation and use of calcium phosphate adsorbed vaccines Developments in Biological Standardization 65: 131-136
Davie, M. 1977: The preparation of human intestinal calcium-binding proteins Calcified Tissue Research 22(Suppl): 511-515
Volpi, M.; Naccache, P.H.; Sha'afi, R.I. 1982: Preparation of inside-out membrane vesicles from neutrophils capable of actively transporting calcium Biochemical and Biophysical Research Communications 106(1): 123-130
Kaledin, V.I.; Glazko, T.T.; Gruntenko, E.V. 1978: Preparation of pills containing azo dyes for subcutaneous administration to animals Voprosy Onkologii 24(5): 82-83
Frick, P.; Frey, R. 1990: Eosinophilia-myalgia syndrome following administration of a L-tryptophan preparation Schweizerische Medizinische Wochenschrift 120(44): 1633-1635
Molchan, I.; Motylova, A.; Khalabala, I. 1977: Administration of a slow-acting lithium preparation (preliminary report) Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 77(8): 1241-1243
Gutiérrez, E.; González, E.; Hernández, E.; Herrero, J.C.; Manzanera, M.J.; García, J.A.; Domínguez-Gil, B.; Praga, M. 2004: Acute hyperphosphatemia secondary to phosphate administration for bowel preparation Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24(3): 283-287